THE ARM IS NOT
THE BREAKTHROUGH.

Precision robotics exists. Intelligence does not. SurgiBot is being developed around the harder problem.

BUILT TO PERCEIVE, REASON AND ACT

SurgiBot is conceived as a multi-arm surgical robot: articulated instrument arms, surgeon-grade vision and a compact operating-room platform. Its defining difference is inside—the ability to learn from governed surgical data and progress from assistance toward bounded autonomous action.

SEE

Fuse 4K, ICG and procedural signals into a live understanding of the surgical field.

UNDERSTAND

Recognise anatomy, instruments, workflow stage and safety boundaries.

PLAN

Select a validated sequence of movements for a defined surgical task.

ACT

Execute precise motion with continuous monitoring and human override.

HOW SURGIBOT LEARNS FROM SURGERY

Spectra systems capture consented surgical signals. CogniAxis.AI de-identifies, structures and labels the data; models learn surgical anatomy, workflow and expert technique; simulations and controlled studies test performance before any bounded capability reaches the robot.

80MSURGERIES — DATA VISION

SurgiBot's development programme targets learning from a governed corpus representing up to 80 million surgeries, subject to lawful access, consent, data rights, quality controls and applicable regulatory requirements.

ONE LOOPSURGERY → INTELLIGENCE → ACTION

Each validated deployment can return governed performance data to improve the system.

2030 ROADMAP

2030 is the early autonomy target. The programme is expected to begin with repeatable, lower-complexity tasks and selected procedural steps—not unrestricted autonomous surgery.

DIAGNOSTIC LAPAROSCOPY

Systematic visual survey, landmark recognition and documentation.

TISSUE RETRACTION AND CAMERA CONTROL

Stable visualisation and coordinated instrument positioning.

CHOLECYSTECTOMY ASSISTANCE

Exposure, anatomy recognition and selected standardised steps.

APPENDECTOMY STEPS AND TURP

Identification, controlled dissection, camera control and selected repeatable steps under specialist supervision.

2030 targets are development ambitions, not clinical promises. Scope and timing will depend on engineering validation, clinical evidence, ethics review, regulatory authorisation, patient selection and human oversight.

HUMAN CONTROL AT EVERY STAGE

✓ Surgeon override✓ Defined operating boundaries✓ Continuous safety monitoring✓ Traceable decisions✓ Progressive clinical validation✓ Regulatory pathway

SurgiBot will advance through supervised task autonomy before any consideration of broader procedural autonomy.

DISCUSS SURGIBOT

THE ARM IS NOTTHE BREAKTHROUGH.